41.50
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Finanzdaten der Teva Pharmaceutical Industries Ltd Adr-Aktie (TEVA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
4.02%
4,142.00
|
3,982.00 | 1,500.00 | 4,480.00 | 4,176.00 |
| Cost Of Revenue |
1.09%
1,989.00
|
2,011.00 | 2,056.00 | 2,176.00 | 2,074.00 |
| Gross Profit |
9.18%
2,153.00
|
1,972.00 | 2,656.00 | 2,304.00 | 2,102.00 |
| Depreciation and Amortization |
0.84%
241.00
|
239.00 | 260.00 | 249.00 | 251.00 |
| Operating Income/Loss |
135.43%
-231.00
|
652.00 | 300.00 | 882.00 | 455.00 |
| Nonoperating Income/Loss |
3.70%
-224.00
|
-216.00 | -220.00 | -237.00 | -252.00 |
| Income/Loss From Equity Method Investments |
300.00%
2.00
|
-1.00 | 11.00 | 2.00 | 1.00 |
| Income/Loss From Continuing Operations Before Tax |
204.12%
-455.00
|
437.00 | 1,500.00 | 646.00 | 203.00 |
| Income Tax Expense/Benefit |
80.60%
121.00
|
67.00 | -390.00 | 214.00 | -78.00 |
| Net Income/Loss |
255.83%
-575.00
|
369.00 | 481.00 | 434.00 | 283.00 |
| Basic Average Shares |
0.78%
1,165.00
|
1,156.00 | 1.00 | 1,147.00 | 1,147.00 |
| Diluted Average Shares |
1.19%
1,165.00
|
1,179.00 | 3.00 | 1,164.00 | 1,161.00 |
| Basic Earnings Per Share |
253.12%
-0.49
|
0.32 | 0.42 | 0.38 | 0.25 |
| Diluted Earnings Per Share |
258.06%
-0.49
|
0.31 | 0.41 | 0.37 | 0.24 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):